Numbers by Barron's

A Fourth Covid-19 Vaccine in the U.S. Looks Likely

Episode Summary

The FDA clears a path for Novavax. Franchise Group is in talks to buy Kohl’s. And Target’s surplus inventory is causing headaches. Host: Jackson Cantrell.

Episode Notes

The FDA clears a path for Novavax. Franchise Group is in talks to buy Kohl’s. And Target’s surplus inventory is causing headaches.

Host: Jackson Cantrell.